CompletedPhase 2NCT02556099

EXTEND EXpanding Treatment for Existing Neurological Disease

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Russell Ware, MD, PhD
Cincinnati Children's
Intervention
Hydroxyurea(drug)
Enrollment
43 enrolled
Eligibility
2-17 years · All sexes
Timeline
2014 – 2023

Study locations (1)

Collaborators

Caribbean Institute for Health Research (CAIHR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02556099 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials